Paul Tudor Jones Tudor Investment Corp
Paul Tudor Jones is the founder of Tudor Investment Corporation and a pioneering macro trader. He rose to prominence after navigating the 1987 market crash successfully and has since built a multi-strategy firm spanning global markets. Jones is widely associated with discretionary macro trading, risk management discipline, and high-profile philanthropic efforts in education and the environment.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
RTX Corp
RTX
|
+$34.4M |
| 2 |
LM
Legg Mason, Inc.
LM
|
+$15.7M |
| 3 |
AMTD
TD Ameritrade Holding Corp
AMTD
|
+$12.8M |
| 4 |
ETFC
E*Trade Financial Corporation
ETFC
|
+$12M |
| 5 |
GLIBA
GCI Liberty, Inc. Class A Common Stock (DE)
GLIBA
|
+$8.83M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$44.5M |
| 2 |
CZR
Caesars Entertainment Corporation
CZR
|
+$28.2M |
| 3 |
BOLD
Audentes Therapeutics, Inc
BOLD
|
+$27M |
| 4 |
TIF
Tiffany & Co.
TIF
|
+$21M |
| 5 |
IBKC
IBERIABANK Corp
IBKC
|
+$19.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 18.69% |
| 2 | Technology | 16.96% |
| 3 | Financials | 14.62% |
| 4 | Consumer Discretionary | 8.11% |
| 5 | Industrials | 7.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1076
Cadence Design Systems
CDNS
$87.9B
| – | – |
-12,202
| Closed | -$846K |
|
1077
Celanese
CE
$5.14B
| – | – |
-6,369
| Closed | -$784K |
|
1078
Century Aluminum
CENX
$4.35B
| – | – |
-21,640
| Closed | -$163K |
|
1079
Cerus
CERS
$566M
| – | – |
-14,533
| Closed | -$61K |
|
1080
CEVA Inc
CEVA
$788M
| – | – |
-15,857
| Closed | -$428K |
|
1081
City Holding Co
CHCO
$2.03B
| – | – |
-5,961
| Closed | -$489K |
|
1082
Coherus Oncology
CHRS
$219M
| – | – |
-16,491
| Closed | -$297K |
|
1083
Cigna
CI
$73.3B
| – | – |
-986
| Closed | -$202K |
|
1084
Ciena
CIEN
$56B
| – | – |
-25,799
| Closed | -$1.1M |
|
1085
Colliers International
CIGI
$5.47B
| – | – |
-6,371
| Closed | -$497K |
|
1086
Core Laboratories
CLB
$574M
| – | – |
-15,523
| Closed | -$585K |
|
1087
Clarivate
CLVT
$1.33B
| – | – |
-130,902
| Closed | -$2.2M |
|
1088
Clorox
CLX
$12.9B
| – | – |
-1,782
| Closed | -$274K |
|
|
CMA
1089
DELISTED
Comerica
CMA
| – | – |
-51,854
| Closed | -$3.72M |
|
1090
Comcast
CMCSA
$95.3B
| – | – |
-24,630
| Closed | -$1.11M |
|
1091
CMS Energy
CMS
$21.4B
| – | – |
-4,731
| Closed | -$297K |
|
1092
Conduent
CNDT
$250M
| – | – |
-12,914
| Closed | -$80K |
|
1093
Cinemark Holdings
CNK
$4.24B
| – | – |
-127,939
| Closed | -$4.33M |
|
1094
Cannae Holdings
CNNE
$672M
| – | – |
-5,594
| Closed | -$208K |
|
|
VISN
1095
Vistance Networks Inc
VISN
$2.59B
| – | – |
-31,746
| Closed | -$450K |
|
1096
Copart
CPRT
$31.3B
| – | – |
-48,536
| Closed | -$1.1M |
|
1097
Capri Holdings
CPRI
$1.55B
| – | – |
-42,821
| Closed | -$1.63M |
|
1098
Crocs
CROX
$5.85B
| – | – |
-17,003
| Closed | -$712K |
|
1099
Constellium
CSTM
$3.66B
| – | – |
-35,165
| Closed | -$471K |
|
1100
CSX Corp
CSX
$95.6B
| – | – |
-86,634
| Closed | -$2.09M |
|
Similar funds
Paul Tudor Jones's Q1 2020 Portfolio in Review
As of Q1 2020, Paul Tudor Jones held 1,500 positions worth $1.12B, down 50% from $2.23B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Paul Tudor Jones withdrew a net $741M in Q1 2020, closing 486 positions and reducing 367 holdings. Its most notable exit was Audentes Therapeutics, Inc, an estimated $27M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 19% of assets, up from 18% a quarter earlier, followed by Technology and Financials.
Against the trend, Paul Tudor Jones opened a new position in GCI Liberty, Inc. Class A Common Stock (DE) worth $7.42M.
- Paul Tudor Jones's largest Q1 2020 buy was GCI Liberty, Inc. Class A Common Stock (DE): 130,150 shares worth $7.42M.
- Paul Tudor Jones added most to RTX Corp in Q1 2020, an estimated $34.4M increase.
- Paul Tudor Jones's biggest Q1 2020 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $44.5M.
- Paul Tudor Jones fully exited Audentes Therapeutics, Inc in Q1 2020, selling an estimated $27M.
- Paul Tudor Jones's ten largest holdings make up 28% of its $1.12B portfolio in Q1 2020.
- Paul Tudor Jones opened 388 new positions and closed 486 in Q1 2020.
- Paul Tudor Jones's portfolio value fell 50% quarter-over-quarter to $1.12B.
Based on Tudor Investment Corp's 13F filing for Q1 2020, filed 15 May 2020.